Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: An Exploratory Open-Label Phase 2 Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Brief Summary: The investigators hypothesize that EPI-743 may provide clinical benefit to children with Autism Spectrum Disorder.